Why We Expect The FDA To Approve Aveo's Tivozanib
Seeking Alpha
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
- AbbVie
- Achillion
- Aegerion
- Amarin
- Arena Pharmaceuticals
- AstraZeneca
- Aveo Pharmaceutical
- Biogen Idec
- Bristol-Myers Squibb
- Delcath
- Dendreon
- Depomed
- Gilead
- GSK
- Merck
- NewLink Genetics
- Raptor Pharmaceuticals
- Rigel
- Sangamo BioSciences
- Sucampo
- Titan Pharmaceuticals
- Valeant Pharmaceuticals
- Vertex Pharmaceuticals
- Vivus
- Zogenix
3 Small Cap Biopharmas Primed To Move Much Higher Now
Seeking Alpha
Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
Seeking Alpha
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha